Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Israel approves 19 new West Bank settlements in major annexation push - 2Manual for 6 Busssiness Class Flights
- 3Top German court to rule on claims by Wirecard shareholders
- 4Coalition led by Iraqi PM al-Sudani wins parliamentary elections
- 5Step by step instructions to Keep up with Great Hand Cleanliness Before Handshakes
- Watch live as near-Earth asteroid Eros buzzes the Andromeda Galaxy on Nov. 30 (video)
- Tech Development Disclosed: A Survey of \Usefulness and Configuration in Concentration\ Tech Item
- Embrace the Outside: Exercises and Entertainment
- Cannabis reclassification could 'open the floodgates' for research, scientists say
- Wedding trip Objections in the US
- The Most Paramount Crossroads in Olympic History
- Uncover the Manageable Fish Practices: Sea agreeable Feasting
- Terminal cancer diagnosis announced by JFK's granddaughter
- PA accuses Israel of 'human trafficking' after planeload of Gazans arrives in South Africa
